Protocol ID

Official Title

Principal Investigator


Disease Site


GCC-19-049 #


Phase 2 Trial of Indoximod with Chemotherapy and Radiation for Children with Progressive Brain Tumors or Newly Diagnosed DIPG Dr. Theodore (Ted) Johnson Robin Dobbins Glioblastoma, Medulloblastoma, Ependymoma, Diffuse Intrinsic Pontine Glioma II

NMTRC012 #


Pediatric Precision Laboratory Advanced Neuroblastoma Therapy- A Study Using Molecular Guided Therapy with Induction Chemotherapy followed by a Randomized Controlled Trial of standard immunotherapy with or without DFMO followed by DFMO maintenance for Subjects with Newly Diagnosed High-Risk Neuroblastoma Dr. Colleen McDonough Bethany Sanstrum Neuroblastoma II

NMTRC014 #


NMTT - Neuroblastoma Maintenance Therapy Trial
Using Difluoromethylornithine (DFMO); NMTRC014
Dr. Colleen McDonough Bethany Sanstrum  Neuroblastoma  II